strongyloidiasi
one
neglect
tropic
diseas
estim
million
peopl
worldwid
infect
stercorali
major
case
tropic
subtrop
countri
unlik
nematod
worm
may
persist
human
bodi
decad
follow
initi
infect
longev
strongyloid
relat
uniqu
complex
life
cycl
altern
freeliv
parasit
cycl
propens
autoinfect
multipl
within
infect
host
review
prison
world
war
ii
unit
kingdom
indic
still
probabl
veteran
remain
aliv
britain
strongyloid
infect
although
infect
mild
immunocompet
patient
sever
fatal
dissemin
diseas
tend
occur
immunocompromis
patient
hyperinfect
syndrom
develop
immunosuppress
reduc
immun
surveil
result
augment
normal
life
cycl
parasit
lead
dramat
increas
densiti
larva
larva
prolifer
intens
duodenum
migrat
bowel
wall
move
lung
back
small
bowel
immunosuppress
secondari
corticosteroid
main
risk
factor
howev
associ
human
tlymphotrop
viru
type
confect
organ
transplant
patient
patient
receiv
chemotherapi
increas
risk
sinc
present
diseas
nonspecif
mani
patient
discov
late
anticip
poor
outcom
student
underw
mismatch
deceas
donor
renal
transplant
figur
receiv
basiliximab
induct
therapi
follow
daili
tacrolimu
prednisolon
mycophenol
day
present
local
hospit
nausea
vomit
diarrhea
kg
weight
loss
mycophenol
stop
without
success
esophagogastroduodenoscopi
egd
reveal
mild
reflux
esophag
sigmoidoscopi
show
signific
chang
rectal
biopsi
disclos
chronic
inflamm
eosinophil
infiltr
howev
parasit
identifi
likewis
stool
analysi
neg
ova
parasit
evid
cmv
coliti
cmv
igm
neg
receiv
albendazol
mg
twice
daili
three
day
improv
investig
mycobacteria
neg
includ
sputum
smear
acidfast
bacilli
afb
polymeras
chain
reaction
pcr
cultur
chest
computer
tomographi
ct
abdomen
pelvi
normal
complet
blood
count
essenti
normal
apart
lymphopenia
eosinophil
count
also
normal
bone
marrow
aspir
cultur
normal
specif
stain
leishmania
neg
cours
hospit
complic
episod
confus
brain
ct
scan
disclos
old
ischem
chang
cerebrospin
fluid
csf
examin
perform
label
reactiv
psychosi
start
citalopram
develop
fever
secondari
extend
spectrum
blactamas
esbl
e
coli
urosepsi
bacteremia
treat
ertapenem
week
followup
blood
cultur
neg
concurr
renal
function
start
deterior
renal
biopsi
consist
earli
acut
vascular
reject
respond
puls
methylprednisolon
dose
antithymocyt
globulin
atg
reestablish
dialysi
took
discharg
attend
centr
similar
symptom
diarrhea
continu
rang
timesday
weight
kg
moreov
complain
cough
wheez
short
breath
sob
oxygen
satur
drop
portabl
chest
xray
cxr
show
bilater
perihilar
infiltr
figur
ct
scan
reveal
bilater
widespread
centrilobular
nodul
ground
glass
opac
consist
hypersensit
pneumon
bronchiol
figur
b
echocardiogram
disclos
normal
left
ventricular
systol
function
eject
fraction
addit
clinic
radiolog
improv
despit
repeat
ultrafiltr
session
oseltamivir
piperacillintazobactam
bronchodil
supplement
oxygen
start
bronchoscopi
bronchoalveolar
lavag
bal
neg
merscov
influenza
virus
pneumocysti
jiroveci
parasit
complet
blood
count
show
hemoglobin
gdl
wbc
cellsl
eosinophil
cellsl
serum
ferritin
creactiv
protein
high
ngml
mgl
success
normal
rang
ferritin
ngml
crp
mgl
serum
albumin
gl
blood
urin
cultur
posit
multidrugresist
mdr
e
coli
receiv
week
meropenem
stool
examin
show
numer
stercorali
larva
multipl
occas
figur
b
nevertheless
repeat
sputum
analysi
bal
specimen
neg
parasit
diagnosi
recurr
e
coli
bacteremia
hyperinfect
syndrom
made
immunosuppress
drug
discontinu
steroid
taper
start
oral
ivermectin
daili
two
week
stool
turn
neg
third
day
treatment
interestingli
cmv
dna
viral
load
also
elev
cpml
day
start
ivermectin
treatment
regress
cpml
week
intraven
ganciclovir
prior
discharg
weight
increas
kg
pulmonari
infiltr
regress
cxr
oxygen
satur
remain
room
air
discharg
home
valganciclovir
cotrimoxazol
prednisolon
followup
day
show
increas
bodi
weight
kg
hemoglobin
gdl
wbc
cellsl
eosinophil
cellsl
normal
albumin
consid
second
transplant
addit
reactiv
chronic
infect
recipi
sot
recipi
may
acquir
infect
infect
graft
acquisit
new
infect
challeng
identifi
patient
sourc
infect
gener
strongyloidiasi
uncommon
saudi
arabia
howev
number
organ
donor
indian
subcontin
southeast
asia
infect
preval
consequ
graftrel
infect
increasingli
report
middl
east
donor
indian
origin
eosinophil
count
normal
twin
recipi
kidney
affect
worth
note
recipi
cyclosporin
three
kuwaiti
kidney
transplant
recipi
two
deceas
donor
die
within
month
hyperinfect
strongyloid
fourth
recipi
twin
kidney
cyclosporin
manifest
diseas
increas
evid
cyclosporin
direct
antiparasit
activ
may
provid
protect
hyperinfect
syndrom
infect
wellknown
risk
factor
hyperinfect
syndrom
high
product
observ
patient
coinfect
stercorali
decreas
product
ige
molecul
particip
host
defenc
mechan
helminth
moreov
decreas
efficaci
treatment
stercorali
patient
coinfect
convers
combin
cmv
strongyloidiasi
report
case
customarili
detect
postmortem
cmv
target
differ
subset
antigenpres
cell
lead
shortliv
immunosuppress
immunocompet
well
immunosuppress
patient
patient
extens
pulmonari
infiltr
ground
glass
appear
wide
centrilobular
nodul
differenti
diagnosi
time
includ
pulmonari
edema
ard
howev
aggress
fluid
remov
lead
either
clinic
radiolog
improv
although
cmv
isol
bal
analysi
cmv
pneumon
remain
like
diagnosi
korean
studi
cmv
pneumonia
nonaid
immunocompromis
patient
common
find
hrct
scan
includ
bilater
mix
area
ground
glass
opac
poorli
defin
centrilobular
small
nodul
consolid
hypersensit
superimpos
bacteri
infect
could
contribut
radiolog
chang
regress
prior
discharg
gener
hyperinfect
syndrom
associ
signific
morbid
mortal
avoid
earli
diagnosi
treatment
untreat
mortal
rate
dissemin
diseas
approach
hematopoiet
stem
cell
transplant
recipi
particularli
poor
outcom
mortal
reach
equal
mortal
reach
renal
transplant
partli
relat
delay
diagnosi
initi
treatment
well
accompani
gramneg
sepsi
propos
larva
carri
colon
bacteria
migrat
venou
system
lead
transloc
blood
tissu
includ
mening
commonli
report
organ
includ
gramneg
rod
e
coli
gramposit
cocci
instanc
streptococcu
bovi
recurr
e
coli
bacteremia
bovi
mening
one
manifest
transloc
thu
bovi
bacteremia
andor
mening
prompt
search
strongyloid
infect
transplant
patient
diagnosi
hyperinfect
syndrom
difficult
although
eosinophilia
common
find
patient
chronic
strongyloid
infect
unreli
predictor
hyperinfect
syndrom
peopl
chronic
strongyloidiasi
mild
peripher
eosinophilia
elev
ige
level
howev
peripher
eosinophilia
present
case
dissemin
infect
similar
patient
present
absenc
eosinophilia
receiv
corticosteroid
therapi
reliabl
exclud
underli
strongyloid
infect
laboratori
confirm
strongyloidiasi
base
mainli
detect
strongyloid
larva
microscop
examin
stool
sputum
csf
dissemin
infect
initi
direct
fecal
smear
stool
examin
refer
hospit
neg
multipl
specimen
posit
hospit
could
due
earli
present
first
admiss
florid
syndrom
time
present
hospit
well
poor
techniqu
parasit
isol
singl
stool
examin
fail
identifi
larva
case
diagnost
sensit
stercorali
rise
stool
sampl
seven
stool
exam
requir
reach
sensit
stool
agar
plate
cultur
apc
baermann
cultur
techniqu
higher
yield
compar
microscopi
use
katokatz
techniqu
recent
metaanalysi
evalu
convent
parasitolog
method
found
top
sensit
apc
follow
baermann
techniqu
fect
direct
wet
smear
differ
molecular
method
found
sensit
reliabl
detect
stercorali
sensit
specif
nest
pcr
respect
realtim
pcr
yield
sensit
specif
earli
diagnosi
patient
could
secur
presenc
serolog
serolog
method
sensit
avail
diagnost
tool
varieti
antigen
use
develop
serolog
test
elisa
test
neg
predict
valu
excel
screen
test
strongyloidiasi
number
studi
demonstr
high
sensit
specif
report
test
use
make
diagnosi
screen
importantli
possibl
test
cure
underscor
import
maintain
serolog
test
transplant
center
order
avoid
seriou
infect
treatment
option
includ
albendazol
thiabendazol
ivermectin
recent
cochran
review
ivermectin
proven
effect
albendazol
rr
ci
equal
effect
thiabendazol
toler
rr
ci
usual
given
oral
subcutan
inject
veterinari
formul
retent
enema
use
durat
treatment
hyperinfect
syndrom
variabl
cdc
recommend
ivermectin
per
day
oral
stool
andor
sputum
exam
neg
week
possibl
immunosuppress
therapi
stop
reduc
best
knowledg
first
case
report
strongyloid
hyperinfect
concurr
cmv
infect
gramneg
sepsi
saudi
patient
despit
aggress
diseas
patient
favor
outcom
evalu
second
transplant
